News and media releases from the Surrey Heartlands area
If you have some news to share, would like to see us feature a patient story or simply have a question, then feel free to get in touch with us.
Tirzepatide (Mounjaro®): A new treatment option for managing obesity
If you are eligible for Mounjaro on the NHS, you will be contacted by your GP surgery. Please do not contact them.
Some people living with obesity may be eligible to access tirzepatide (Mounjaro®) for weight loss purposes in community settings as outlined in NICE guidelines.
Access is prioritised for those with the greatest clinical need. The number of people eligible will be small initially, including those people living with obesity, in poor health with multiple obesity related conditions, as they would benefit most from the treatment.